Since 2006, AusDiagnostics has been committed to bringing the benefits of molecular science to the world, to help enable better diagnostic decisions in human diagnostics, animal diagnostics and applied testing. The first MT-PCR panel was introduced in 2006, and since then, through ongoing collaboration with leading clinical laboratories, research institutes and experts, we have been able to deliver beneficial solutions that add value to our customers.
Today our clinical diagnostic products are used by laboratories and hospitals around the world to detect and test for a broad range of diseases and conditions. Our multiplexing platform has also helped to abridge lengthy testing processes for our customers across their different industries. Headquartered in Australia, AusDiagnostics prides itself in its evolution to a multi-national company with subsidiaries in New Zealand, United States and United Kingdom, and manufacturing facilities in Australia and United Kingdom. We have an ever-growing network of over 25 distributors and partners who help us drive a positive impact to customers around the globe.
Purposely driven to improve patient outcomes through diagnostic innovation.
“We live by our reputation.”
We are genuine, open and ethical in the business we conduct and the way in which we conduct it.
“Think outside convention —challenge it.”
We are passionate about continuous improvement. We constantly push the envelope of innovation to create dynamic solutions that add value to our customers.
“We value our people and partners.”
We regard our people and partners in the highest of esteem — we collaborate and connect with dignity and transparency.
“Freedom and power to make a difference.”
We are the unification of the ideas and contributions of our people — we enable individuals to actuate and excel.
“Different individuals on the same journey.”
We celebrate diversity and actively foster an inclusive culture where individuals can form meaningful and crucial connections. We embrace unique ideas and talents because this is what drives innovation and continual growth.
Continual investment into new technology, commercial collaboration, and customer engagement has helped us develop into the international business we are today. With offices based in Australia, New Zealand, United Kingdom and the United States, we have partnered with over 25 distributors to help us to deliver our diagnostic solutions to customers around the world.
The AusDiagnostics corporate headquarters in Mascot, Sydney Australia house our state-of-the-art purpose-built PC2 laboratories which are operated by specialised teams of molecular scientists and engineers who are dedicated to manufacturing high-quality reagents and robotics.
We continually strive to be readily accessible to our customers. In July 2017, the New Zealand office was established to bolster support for local customers with a dedicated sales and service capability.
AusDiagnostics UK was established in 2013 to strengthen our support to our global distribution network. It is home to a dedicated team who look after ongoing distributor partnerships across EMEA. Experiencing continual growth since then, an EN ISO 13485:2016 accredited manufacturing facility was established in 2018 to improve our ability to supply our products and services across the northern parts of the world.
AusDiagnostics sales and service support in the US is managed from our Texas base. Since establishment in October 2017, it has been an important hub to support our US customers by seasoned sales and service specialists.